HANTSON LUDWIG
SEC insider (Form 3/4/5 filer). CIK 0001491435. Director at IONIS PHARMACEUTICALS INC (IONS) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 15, 2026. Located in CARLSBAD, CA.
Companies HANTSON LUDWIG has filed insider reports for
- IONIS PHARMACEUTICALS INC (IONS): Director
- HOLOGIC INC (HOLX): Director
HANTSON LUDWIG
CIK: 0001491435
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (80.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (20.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jul 15, 2026IONS
IONIS PHARMACEUTICALS INC
AwardDirectRestricted Stock Unit
3.4K shares- - Jun 4, 2026IONS
IONIS PHARMACEUTICALS INC
AwardDirectNon-Qualified Stock Option (right to buy)
10.8K shares- - Apr 7, 2026HOLX
HOLOGIC INC
DispositionDirect16.1K shares- - Feb 26, 2026HOLX
HOLOGIC INC
AwardDirect3.2K shares- - Feb 26, 2025HOLX
HOLOGIC INC
AwardDirect1.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 15, 2026 |  IONS IONIS PHARMACEUTICALS INC | Award Restricted Stock Unit | 3,399 | - | - | Direct |
| Jun 4, 2026 | IONS IONIS PHARMACEUTICALS INC | Award Non-Qualified Stock Option (right to buy) | 10,753 | - | - | Direct |
| Apr 7, 2026 |  HOLX HOLOGIC INC | Disposition | 16,146 | - | $0 | Direct |
| Feb 26, 2026 | HOLX HOLOGIC INC | Award | 3,190 | - | $0 | Direct |
| Feb 26, 2025 | HOLX HOLOGIC INC | Award | 1,864 | - | - | Direct |
1-5 of 5 transactions